Exact Mass: 614.4546

Exact Mass Matches: 614.4546

Found 127 metabolites which its exact mass value is equals to given mass value 614.4546, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,7Z,10Z,13Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,7Z,10Z,13Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C38H62O6 (614.4546)

DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-13:0)

(2S)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(a-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (4Z,7Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C38H62O6 (614.4546)

DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C38H62O6 (614.4546)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoate

C38H62O6 (614.4546)

DG(i-13:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoate

C38H62O6 (614.4546)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-[(2,3,4-trihydroxy-5-methylcyclohexyl)methyl]-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C38H62O6 (614.4546)

(4as,9s,10s,10as)-6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl octadecanoate

C38H62O6 (614.4546)

6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl octadecanoate

C38H62O6 (614.4546)